Related Experiment Videos
Lithium treatment in Aarhus. 1. Prevalence
1Department A, Psychiatric Hospital, Risskov, Denmark.
Pharmacopsychiatry
|May 1, 1989
Summary
Lithium treatment prevalence was assessed in a population of 372,000. Approximately 1.5 per 1000 individuals received lithium therapy, indicating its usage in psychiatric care.
Area of Science:
- Psychiatry
- Pharmacology
- Epidemiology
Background:
- Lithium is a mood-stabilizing medication.
- Understanding lithium treatment prevalence is crucial for resource allocation and public health planning.
Purpose of the Study:
- To determine the point prevalence of lithium treatment in a defined geographical region.
- To provide data on lithium usage in psychiatric care.
Main Methods:
- Data collection through submitted information and serum lithium level analyses.
- Study conducted in 1986-1987 in a region with approximately 372,000 inhabitants.
- Prevalence calculation with correction for incidence.
Main Results:
- The study found that 1 in every 689 individuals, or approximately 1.5 per 1000 persons, were receiving lithium treatment at any given time.
- This represents the point prevalence of lithium therapy in the studied population.
Conclusions:
- Lithium treatment had a specific prevalence within the studied population during the specified period.
- The findings offer insights into the utilization of lithium in psychiatric practice.